承诺中华，再添力证！诺华可善挺®化脓性汗腺炎新适应症在华获批，重塑HS治疗格局

文中涉及的核心术语定义：EADV即欧洲皮肤病与性病学会（European Academy of Dermatology and Venereology）年会；AAD即美国皮肤病学会（American Academy of Dermatology）年会。

主要终点指标包括总生存期（OS）。

来源：拓麦精要

参考文献：

中国反常性痤疮,化脓性汗腺炎诊疗专家共识制订小组. 中国反常性痤疮,化脓性汗腺炎诊疗专家共识（2021版）[J].中华皮肤科杂志, 2021, 54(2) : 97-104.
Phan, K., et al. biomed dermatol 4, 2(2020).
Garg A, et al. J Am Acad Dermatol 2020;82(2):366-76.
Ingram JR,et al. J Eur Acad Dermatol Venereol 2022:36(9): 1597-605.4. Cho YT, et al. J Formos Med Assoc. 2022 Jul;121(7):1191-1203
Reddy S, et al.JAMA Dermatol. 2019 Jul 1;155(7):797-802
Krajewski PK,et al. Acta Derm Venereol. 2021 Jan 5;101(1):adv00364.
Matusiak Ł,et al. 2010;62(4):706-708
Sabat R, et al.Nat Rev Dis Primers. 2020 Mar 12;6(1):18. 2.
van Straalen KR, et al.J Am Acad Dermatol. 2021 Aug;85(2):369-378.
Ravi S,et al. JAMA Dermatol. 2022 Feb 1;158(2):132-141.
Savage KT, et al.Ther Adv Chronic Dis. 2019 May 27;10:2040622319851640.
Gianna Melendez,2021, EADV abstract
Zouboulis CC,et al. Akt Dermatol. 2024;50:30-83
Ingram JR,. et al.Br J Dermatol. 2019 May;180(5):1009-1017.
Sabat R,et al. Nat Rev Dis Primers. 2020;6(1):18.
Kimball AB et al.LB-3549. EADV congress; September 7-10, 2022; Milan, ltaly.
Kimball AB, et al. Lancet.2023;401(10378):747-761
John R. Ingram, et al. Presented at the AAD congress, March 7-11, 2025.
Jennifer L. Hsiao, et al. Presented at the AAD congress, March 7-11, 2025.
Alexa B. Kimball, et al. Presented at the AAD congress, March 7-11, 2025.

2025-03-24

承诺中华，再添力证！诺华可善挺®化脓性汗腺炎新适应症在华获批，重塑HS治疗格局的核心信息是什么？